Highly phagocytic, CD4hi, CD14hi and CD16hi antigen-presenting cells modulated by tumour-conditioned media retain the capacity to mature and induce TH1 T-cell proliferation

This publication has 54 references indexed in Scilit:

• Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes
  Molecular Immunology, 2005
• Immunotherapy and immunoselection - tumour escape as the final hurdle
  FEBS Letters, 2004
• Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system
  Journal of Leukocyte Biology, 2004
• In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats
  Gastroenterology, 2003
• High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells
  Transplant Immunology, 2003
• Serum interleukin-6 concentrations as predictive factor of time to progression in metastatic malignant melanoma patients treated by biochemotherapy: a retrospective study
  Cytokines, Cellular & Molecular Therapy, 2002
• Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xL
  Published by Elsevier ,2001
• The gp130-stimulating designer cytokine hyper-IL-6 promotes the expansion of human hematopoietic progenitor cells capable to differentiate into functional dendritic cells
  Experimental Hematology, 2000
• IN VIVO DESCRIPTION OF DENDRITIC CELLS IN HUMAN RENAL CELL CARCINOMA
  Journal of Urology, 1999
• Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor‐infiltrating lymphocytes
  International Journal of Cancer, 1995